Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-13 Sale | 2024-12-16 4:35 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director | 7,000 | $7.54 | $52,780 | 86,638 (Direct) | View |
| 2024-06-24 Sale | 2024-06-25 4:39 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | McKee Amy E Director | 8,600 | $6.32 | $54,352 | 27,831 (Direct) | View |
| 2024-06-17 Sale | 2024-06-17 4:31 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | SANDERS MACHELLE Director | 4,689 | $6 | $28,134 | 27,742 (Direct) | View |
| 2024-06-14 Sale | 2024-06-14 4:25 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 6,698 | $6.11 | $40,925 | 102,785 (Direct) | View |
| 2024-05-30 Purchase | 2024-05-31 4:25 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director | 7,861 | $6.36 | $49,996 | 44,951 (Direct) | View |
| 2024-05-24 Purchase | 2024-05-29 4:16 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 2,500 | $6.4 | $16,000 | 65,839 (Indirect Direct) | View |
| 2024-05-20 Purchase | 2024-05-22 07:24 am | BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director | 5,000 | $6.38 | $31,900 | 86,818 (Direct) | View |
| 2024-05-20 Purchase | 2024-05-22 07:21 am | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 15,000 | $6.25 | $93,750 | 66,997 (Direct) | View |
| 2024-05-14 Purchase | 2024-05-15 07:19 am | BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer | 36,300 | $5.57 | $202,191 | 266,744 (Direct) | View |
| 2024-05-14 Purchase | 2024-05-15 07:17 am | BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer | 30,000 | $5.86 | $175,800 | 272,139 (Direct) | View |
| 2024-05-13 Purchase | 2024-05-15 07:14 am | BIOCRYST PHARMACEUTICALS INC | BCRX | Galson Steven K Director | 21,940 | $5.49 | $120,451 | 51,551 (Direct) | View |
| 2024-05-13 Purchase | 2024-05-15 07:11 am | BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer | 5,000 | $5.53 | $27,650 | 300,762 (Direct) | View |
| 2024-05-13 Purchase | 2024-05-15 07:08 am | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 30,000 | $5.55 | $166,500 | 1,167,770 (Indirect Direct) | View |
| 2024-05-13 Purchase | 2024-05-15 07:04 am | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 30,000 | $5.47 | $164,100 | 307,533 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-14 Tax Withholding | 2024-12-17 4:22 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 8,251 | $7.53 | 300,057 (Direct) | View |
| 2024-12-14 Tax Withholding | 2024-12-17 4:16 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 27,525 | $7.53 | 1,141,019 (Direct) | View |
| 2024-12-14 Tax Withholding | 2024-12-17 4:10 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer | 8,613 | $7.53 | 294,490 (Direct) | View |
| 2024-12-14 Tax Withholding | 2024-12-17 4:06 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer | 7,890 | $7.53 | 259,628 (Direct) | View |
| 2024-12-14 Tax Withholding | 2024-12-17 4:03 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer | 7,150 | $7.53 | 264,989 (Direct) | View |
| 2024-11-29 Option Award | 2024-12-02 4:06 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 750 | $7.5 | 76,084 (Direct) | View |
| 2024-08-30 Option Award | 2024-09-03 4:17 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 647 | $8.69 | 75,334 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:33 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | SANDERS MACHELLE Director | 56,753 | $0 | 82,364 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:31 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 56,753 | $0 | 124,620 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:30 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | McKee Amy E Director | 56,753 | $0 | 86,364 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:28 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | LEVIN ALAN G Director | 56,753 | $0 | 101,704 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:27 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director | 56,753 | $0 | 143,571 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:25 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 56,753 | $0 | 102,785 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:23 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | Galson Steven K Director | 56,753 | $0 | 108,304 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:20 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 56,753 | $0 | 122,592 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:18 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | ABERCROMBIE GEORGE B Director | 56,753 | $0 | 86,364 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-03 4:33 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 870 | $6.46 | 52,730 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-03 4:29 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 870 | $6.46 | 67,867 (Direct) | View |
| 2024-03-31 Tax Withholding | 2024-04-02 4:21 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer | 7,525 | $5.08 | 242,139 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 5:25 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | MILANO VINCENT Director | 999 | $5.63 | 51,997 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:32 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director | 999 | $5.63 | 51,860 (Direct) | View |
| 2024-01-03 Gift | 2024-01-04 4:31 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 30,000 | $0 | 1,114,770 (Direct) | View |
| 2023-12-19 Tax Withholding | 2023-12-20 4:42 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Thackray Helen M. Chief R&D Officer | 5,580 | $6.05 | 249,664 (Direct) | View |
| 2023-12-19 Tax Withholding | 2023-12-20 4:40 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO | 14,089 | $6.05 | 1,134,770 (Direct) | View |
| 2023-12-19 Tax Withholding | 2023-12-20 4:38 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Chief Commercial Officer | 2,482 | $6.05 | 274,533 (Direct) | View |
| 2023-12-19 Tax Withholding | 2023-12-20 4:35 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer | 2,482 | $6.05 | 227,444 (Direct) | View |
| 2023-12-19 Tax Withholding | 2023-12-20 4:33 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Chief Legal Officer | 2,482 | $6.05 | 293,539 (Direct) | View |